Imagine a future where doctors can predict the course of breast cancer with unprecedented accuracy, leading to personalized treatment plans that offer the best...
Breast cancer, specifically the estrogen receptor-positive (ER+) type, is a major cause of death from cancer among women.
The primary treatment, endocrine therapy, faces...
Carrick Therapeutics, a company focused on creating new cancer treatments, has recently started a significant study (Phase 1b/2 clinical trial) to test a combination...
A new multi-institutional study, led by a team of researchers including Prof Carlo Palmieri, Prof Hannah Linden, and others, investigated the effectiveness and safety...
Recent advancements in the research of hormone therapy resistance in advanced estrogen receptor (ER) positive breast cancers has revealed important considerations for future treatment.
A...